Akoya Biosciences Inc. held a special meeting of stockholders on July 7, 2025. Stockholders approved the proposal to adopt the Amended and Restated Agreement and Plan of Merger involving Quanterix Corporation, Wellfleet Merger Sub, Inc., and Akoya Biosciences, Inc. Additionally, stockholders approved the proposal to adjourn the meeting if necessary to solicit additional proxies for the merger proposal. However, since the merger proposal was approved, the meeting was not adjourned.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.